| Metric | შპს ნიუ ფარმა NEW PHARMA | შპს მაქსფარმა |
|---|---|---|
| Growth | ||
| Revenue | ₾6.0m₾6.9m | ₾1.8m₾2.6m |
| Revenue growth | -12.4% | -28.2% |
| Profitability | ||
| EBITDA | -₾474k₾1.6m | -₾67k-₾87k |
| EBITDA margin | -7.9%24.1% | -3.7%-3.4% |
| Net profit | -₾496k₾1.6m | -₾67k-₾87k |
| Net margin | -8.3%23.2% | -3.7%-3.4% |
| Balance sheet | ||
| Total assets | ₾894k₾1.2m | ₾202k₾251k |
| Total equity | -₾493k₾97k | -₾26k₾42k |
| ROE | —1630.2% | —-209.3% |